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Abstract
Background: Intravenous (IV) fluid administration is an essential part of postoperative care. Some
studies suggest that a restricted post-operative fluid regime reduces complications and
postoperative hospital stay after surgery. We investigated the effects of postoperative fluid
restriction in surgical patients undergoing major abdominal surgery.
Methods: In a blinded randomized trial, 62 patients (ASA I-III) undergoing elective major
abdominal surgical procedures in a university hospital were allocated either to a restricted (1.5 L/
24 h) or a standard postoperative IV fluid regime (2.5 L/24 h). Primary endpoint was length of
postoperative hospital stay (PHS). Secondary endpoints included postoperative complications and
time to restore gastric functions.
Results: After a 1-year inclusion period, an unplanned interim analysis was made because of many
protocol violations due to patient deterioration. In the group with the restricted regime we found
a significantly increased PHS (12.3 vs. 8.3 days; p = 0.049) and significantly more major
complications: 12 in 30 (40%) vs. 5 in 32 (16%) patients (Absolute Risk Increase: 0.24 [95%CI: 0.03
to 0.46], i.e. a number needed to harm of 4 [95%CI: 2–33]). Therefore, the trial was stopped
prematurely. Intention to treat analysis showed no differences in time to restore gastric functions
between the groups.
Conclusion: Restricted postoperative IV fluid management, as performed in this trial, in patients
undergoing major abdominal surgery appears harmful as it is accompanied by an increased risk of
major postoperative complications and a prolonged postoperative hospital stay.
Trial registration: Current Controlled Trials ISRCTN16719551
Background
Fluid administration during and after abdominal surgery
is an essential part of postoperative care to maintain the
patients' fluid and biochemical balance. Abdominal surgi-
cal procedures are associated with dehydration from pre-
operative fasting, bowel preparation, and intra- and post-
operative fluid and electrolyte loss [1]. In clinical practice,
in particular in major aortic and abdominal surgery, it is
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even in excess of actual losses [1]. Concern about preop-
erative fluid deficits, support of circulation and cardiac
function after general and regional anesthesia, control of
postoperative circulation, avoidance of blood transfusion
and preservation of urine output are all issues that are
thought to account for the administration of these exces-
sive amounts of fluid [1]. However, in thoracic surgery a
more "dry" regime is usually applied in order to prevent
pulmonary complications [2]. That postoperative fluid
overload might not be a benign problem has already been
reported in 1990 [3].
At present, controversy exists as to the optimum volume
of intravenous fluids during and after general surgery [4].
In minor (day-care) surgery for dental, laparoscopic or
gynecological procedures, intraoperative fluid restriction
(1–2 ml/kg) did not appear beneficial to patient recovery
and well-being [5-9]. In larger surgical procedures, some
advocated a high-volume intraoperative fluid intake (40
ml/kg) [10], or a postoperative intake on demand [11],
while others described early oral liquid nutrient intake
and discontinuation of intravenous fluid replacement to
be beneficial [12]. Several small, randomized clinical tri-
als suggested that a restricted intraoperative (4 ml/kg/h)
or postoperative intravenous fluid regime (aiming at a
constant body weight) may reduce hospital stay and post-
operative complications [13], such as delayed gastrointes-
tinal function and patient discomfort [14,15]. An
explanation for this effect is thought to be a diminished
ability of starved patients to excrete an excess of sodium
and water postoperatively, which may cause a fluid over-
load that has adverse effects on gastrointestinal physiol-
ogy and edema formation [1,16,17]. However, a recent
report on patients undergoing elective colorectal surgery
did not found a reduced hospital stay when a restriction
of postoperative intravenous fluid and sodium was
applied [18].
Thus, all the studies mentioned above showed ambiguous
results. Furthermore, blinding was hardly ever used in
these trials. This may have led to therapeutic interventions
before the endpoint of the studies were reached, which in
turn might have confounded the results.
Therefore, we designed and conducted a randomized,
blinded, clinical trial in patients undergoing various
major abdominal surgical interventions to compare the
effect of a standard versus a restrictive postoperative intra-
venous fluid management on hospital stay, complication
rate, and gastrointestinal function.
In our hospital the standard postoperative fluid regime is
at least 2.5 litres/24 h of isotonic fluids. Before the start of
this study, we performed an audit among all other univer-
sity hospitals in the Netherlands on their standard fluid
therapy after abdominal surgery. This audit confirmed
that our postoperative fluid regime was in agreement with
the current standard performed in the Netherlands
[unpublished data]. Therefore, we chose 2.5 litres/24 h as
amount for the standard postoperative intravenous fluid
management and 1.5 litres/24 h for the restrictive fluid
management in this study.
Methods
Patients
The Local Research Ethics Committee approved this study,
and patients were included only after they had given their
written informed consent. The trial was conducted accord-
ing to the highest methodological standards to avoid bias
and described according to the standards of the CON-
SORT statement. All consecutive adult patients with a
physical status ASA I-III and scheduled for elective general
abdominal surgery between May 2004 and July 2005 were
eligible for inclusion. To obtain a representative sample of
routine general major surgical procedures, all types of gas-
tric resections, bowel procedures (small bowel, colon
and/or rectum), bile duct restoring procedures, pancreati-
coduodenectomies, or partial resections of the pancreas
were included. Patients were excluded from the study if
any of the following criteria were present: Scheduled for
laparoscopic, liver or esophageal surgery and/or antici-
pated postoperative stay on the Intensive Care Unit, age
<18 yrs, emergency operation, pregnancy, breastfeeding
period, impaired renal function, significant cardiac dis-
ease (NYHA/CCS ≥ III), presence of diabetes mellitus, pre-
operative IV drip-feeding, contraindications for applying
epidural analgesia or failed attempt or logistical reasons.
Procedures
Patients were approached and enrolled by one of the
researchers (HV, DU or MSV) and subsequently randomly
assigned to receive either a postoperative restricted intra-
venous (IV) fluid regime (RFR; 1.5 L/24 h) or a hospital
standard IV fluid regime (SFR; 2.5 L/24 h). Statistical ran-
domization was performed by means of a computer rand-
omization program, to ensure allocation concealment. To
balance both groups, minimization (a method of stratifi-
cation) was performed for gender and age. The result of
this computer randomization was enclosed in a sealed,
opaque envelope and delivered to the nursing ward
shortly before the operation. Also, the necessary equip-
ment for the study (infusion pump, IV-line, clothing bag
to blind the infusion system, and the relevant case report
forms) were delivered. The sealed envelope, together with
all these materials, was sent with the patient entering the
operation room. Disclosure of the randomization took
place at the end of the operation by opening the sealed
envelope.Page 2 of 11
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All patients were admitted the day before surgery. Preop-
erative bowel preparation regime (two enemas), fasting
regime, pre-operative medication, and postoperative
nasogastric intubation were according to the ruling stand-
ards [19]).
Just before surgery a routine epidural catheter was placed
in all patients. Anesthesia for all surgical procedures con-
sisted of a combination of epidural analgesia together
with a balanced anesthesia technique according to the
attending anesthetist. Only the intraoperative IV fluid
infusion regime was according to a standardized protocol
in order to avoid great variation in fluid management just
before the real study randomization took place; i.e. open-
ing the sealed envelope at the end of the operation
(Appendix). One of the researchers (JH or MD) supervised
adherence to this protocol and they also disconnected the
IV lines after the surgical procedure. At the end of the sur-
gical procedure, as described above, the randomization
envelope was opened. Then, only one IV catheter was re-
connected to a new IV fluid line that was led through an
infusion pump (Infusomat® P; B. Braun Medical Inc.,
Bethlehem, PA, USA) and was connected to five (SFR; 2.5
L/24 h) or three (RFR; 1.5 L/24 h) 500 ml fluid bags of
Ringer's Lactate solution simultaneously to secure a con-
stant fluid administration for the first 24 hrs after surgery,
starting upon arrival at the recovery room. The pump infu-
sion rate was set according to the allocated IV fluid
regime. Subsequently, SFR patients received 1500 ml
0.9% NaCl and 1000 ml 5% glucose, while RFR patients
received 1000 ml 0.9% NaCl and 500 ml 5% glucose IV.
Patients, attending physicians, and nurses on the wards
were all blinded to the treatment given. This was ensured
by immediate covering of the infusion bags and pump by
means of an opaque clothing bag. To maintain this blind-
ing on the wards, an independent nurse who was not
assigned to care for the patient was charged to change the
infusion bags every 24 hrs and/or solve any pump prob-
lems. A sheet with pre-defined criteria for discontinuation
of the blinding (and to change the fluid regime if neces-
sary) was attached to the clothing bag. Hence, as long as
these criteria were not met, the fluid regime was contin-
ued according to the initial allocation.
Criteria for discontinuation of the blinding were: mean
arterial blood pressure (MAP) below 50 mm Hg, acute
heart failure, indication for re-operation, and signs of
severe blood loss or shock. Although the presence of urine
flow indicates blood flow to the kidney, oliguria was not
considered a reliable sign of pending renal dysfunction
[20,21].
In both groups, postoperatively, the nasogastric tube was
removed directly after surgery or on the first postoperative
day. Subsequently, patients were free in their oral fluid
intake and received the allocated IV fluid regime until the
attending physician judged this fluid administration
could be discontinued, based on evaluation of the oral
intake and bowel movements of the patient. We choose
routine clinical practice as much as possible to proceed in
this phase and not to use predefined criteria in order to let
this study run as near to common clinical practice as rea-
sonably possible. This chosen strategy is recently sup-
ported by the presented guidelines by Lassen too [22].
Until discontinuation of the IV fluid administration, it
was impossible to use the daily fluid balance as a clinical
monitoring variable because of the blinding. Instead, the
attending residents monitored the patients on the basis of
other parameters, such as the patients' clinical condition,
wound appearance, oral fluid intake, peristalsis, urinary
output, heart rate, blood pressure, and routine laboratory
test results (e.g. hemoglobin, hematocrit, electrolytes,
infection parameters, and kidney function). In the post-
operative period, it was not possible to obtain patients'
weights on a daily basis.
Postoperative analgesia consisted of administering bupi-
vacaine (0.125%) mixed with fentanyl (2.5 mcg/ml) via
the epidural catheter into the epidural space, together
with paracetamol given orally or rectally (1 g, 4 times a
day). After discontinuation of the epidural infusion the
resident managed the further postoperative (analgesic)
treatment and eventual dismissal according to common
clinical practice rules.
Endpoints
Primary endpoint was length of postoperative hospital
stay (PHS), counted from the date of operation, as this
parameter is commonly used in similar studies. Discharge
criteria were: restored peristalsis (i.e. flatus, or defecation
less than 8 times a day), unhampered oral intake of food
and drink, and sufficient mobility to wash and dress. If a
patient had received a stoma, its output should be less
than 1 l/day. Secondary endpoints were major and minor
postoperative complication rates, time to first passage of
flatus and feces, discontinuation of IV fluids and return to
normal diet (all intervals counted from the operation
date). Postoperative complications were recorded accord-
ing to the National Surgical Adverse Event Registration
from the Dutch Society for Surgery during the in-patient
period. The following complications were defined as
'major': death, cardiac events (i.e. myocardial infarction,
arrhythmias, or admission to Coronary Care Unit), anas-
tomotic leakage (based on CT-scan or findings during re-
operation), sepsis, kidney failure requiring dialysis, and
re-admission (i.e. disease-related re-hospitalization
within 30 days after discharge; in these cases the reason
for re-admission was not counted as additional complica-Page 3 of 11
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wound abscess, infection or dehiscence, not requiring sur-
gical reintervention, respiratory disorders or infection,
bleeding, peripheral thrombo-embolism. Kidney func-
tion was not defined as endpoint because in the study by
Lobo et al. none of the patients in the restricted group
became oliguric or had a blood urea concentration above
the upper limit of normal [17].
Sample size calculation
To detect a reduction in PHS of 3 days (SD 5 days), which
is in agreement with the study of Lobo et al. [17], with a
two-sided 5% significance level and a power of 80%, a
sample size of 50 patients per group was necessary, given
an anticipated dropout rate of 10%. To recruit this
number of patients a 12-month inclusion period was
anticipated.
Data collection
Data on patient characteristics, complications, and resto-
ration of gastric function were extracted from the (elec-
tronic) patient dossiers and case report forms (HV, MS).
Raw data regarding the primary and secondary endpoints
were checked by an independent investigator (GB) and all
disagreements were referred to a third reviewer (DU).
Data safety monitoring board
To ensure a proper execution of the trial and to monitor
the progress, outcome, and patient safety during the trial,
its progress and any occurring adverse events were dis-
cussed regularly with an expert team (JH, DL, MD) that
was not involved in the randomization procedure or post-
operative treatment of the patients. No stopping rules
were defined beforehand.
Statistical analysis
Continuous data are presented as means and standard
deviations (SD) or medians and interquartile ranges
(IQR) if they were unevenly distributed. Differences were
tested statistically using the Mann Whitney U-test. A p
value < 0.05 was considered significant. For the analysis of
categorical data we calculated the Absolute Risk Reduc-
tion (ARR) with a 95% confidence interval (95%CI). Data
were analyzed using an intention to treat and per protocol
principle. To detect possible factors associated with the
occurrence of major postoperative complications, we per-
formed stepwise multivariable logistic regression analysis.
For these analyses, SPSS for Windows version 12.0 (SPSS
Inc., Chicago, Ill, USA) software was used. We did not
schedule an interim analysis.
Results
During the inclusion period 343 patients were potentially
suitable for the study. After screening, 271 patients did
not match all inclusion criteria and/or had one or more of
the exclusion criteria. The flow chart of the number of
patients at inclusion, during follow-up and available for
analysis is shown in figure 1. At the end of the anticipated
one-year inclusion period, the desired number of 100
patients was not reached, which jeopardized continuation
of the trial as we had formulated this timeframe before-
hand in our study protocol. Analyzing reasons for not
reaching the expected inclusion level showed that roughly
one third of eligible patients participated in other clinical
trials. It was expected this problem would maintain when
continuation/extension of the trial should be decided.
Furthermore, protocol violations were observed rather fre-
quently because of postoperative hypotension (remaining
above a mean of 50 mmHg, but resulting in the adminis-
tration of an extra bolus of saline i.v.), oliguria (also
resulting in the administration of extra saline i.v.) or infu-
sion pump problems (leading to a lower amount of fluid
administered). This also was thought to be a significant
problem for continuation of the study, however desired.
Finally, nurses and residents, although unaware of the
amount of fluid given, suspected none of the trial patients
received the anticipated benefit from a restricted fluid
regime. All these items were discussed among the investi-
gators and the members of the safety monitoring board.
Then, the decision was made to stop inclusion and to per-
form an unplanned interim analysis of the available data.
We therefore analyzed the results of 62 patients that were
included after one year and had entered the protocol.
Table 1 shows the characteristics of these patients. Dura-
tion and type of surgical procedures were similar in both
treatment arms. Most patients underwent major surgery of
the biliary or pancreatic region.
Although the intra-operative IV fluid management actu-
ally given during surgery was higher than the prescribed
regime, no statistical significant differences were found
between the groups (Table 2). Also, the intra-operative
amounts of blood-loss, blood product administration,
surgical procedure time, urine production and post-oper-
ative length of given epidural analgesia were not different
between the groups (Table 2).
In 19 patients unmasking and discontinuation of the
study protocol occurred (SFR vs. RFR: 7/32 vs. 12/30;
Fisher's exact test: p = 0.17). Reasons for unmasking are
shown in figure 1. Thus, 43 patients could be included in
a per protocol analysis.
In an intention to treat analysis, PHS was significantly
longer in the RFR group; 12.3 vs. 8.3 days; p = 0.049
(Table 3). This difference was not found in the per proto-
col analysis (Table 4). No significant differences were
found between both groups for any of the gastrointestinalPage 4 of 11
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Flow chart of patient inclusion, follow-up, and analysisigure 1
Flow chart of patient inclusion, follow-up, and analysis.
Assessed for eligibility
n=343
Excluded n=281
Participating in other trial n=105
Refused to participate n=  17
Language problem n=   7
No show for admittance n= 10
ASA IV n= 22
1<+$&&6 n= 50
Diabetes mellitus n= 57
Impaired renal function n=   2
Failed epidural attempt n=   8
Logistical problem with material n=   2
Falsely seen as eligible n=   1
Randomised
n=62
Standard IV fluid infusion regime 
(2.5 l per 24 hrs)
n=32
Restricted IV fluid infusion regime 
(1.5 l per 24 hrs)
n=30
Unmasked n=7
- MAP < 50 mmHg n=2
- Severe blood loss n=3
- Infusion pump problems n=2
Unmasked n=12
- MAP < 50 mmHg n=4
- Oliguria n=2
- Re-operation n=2
- Severe blood loss n=1
- Infusion pump problems n=2
- Cardiovascular n=1
Per protocol 
analysis
n=25
Intention to treat 
analysis
n=32
Intention to treat 
analysis
n=30
Per protocol 
analysis
n=18
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tubes, and discontinuation of IV and epidural catheters
(Tables 3 and 4). None of the patients suffered from post-
operative acute kidney injury.
Significantly more (major) postoperative complications
(especially anastomotic leakage) were found in the RFR
group (Table 3), with a Number Needed to Harm of 4
(95% CI: 2–36). This difference disappeared in the per
protocol analysis (Table 4). Anastomotic leakage occurred
in patients who underwent colon surgery (n = 4), pancre-
aticojejunostomy (n = 2), or hepaticojejunostomy (n = 1).
No significant differences were found between the groups
for the minor complications or restoration of gastric func-
tions. In order to avoid the risk of false-positive findings
in our small sample size we refrained from subgroup anal-
ysis. Multivariable logistic regression analysis of potential
factors contributing to the occurrence of complications
did not indicate any significant confounders.
Table 1: Baseline patient characteristics.
Restricted group
(n = 30)
Standard group
(n = 32)
p-value*
Characteristics
Age (yrs) 55.5 (15.4) 53.6 (15.0) 0.623
Sex (Male/Female) 19/11 21/11 0.853
Height (m) 1.73 (0.08) 1.76 (0.08) 0.810
Weight (kg) 69.9 (12.5) 76.5 (17.1) 0.908
BMI 23.2 (4.2) 24.5 (4.7) 0.408
ASA 0.908
1 4 (13%) 5 (16%)
2 21 (70%) 24 (75%)
3 5 (17%) 3 (9%)
Type of surgery 0.522
-Gastric 0 (0%) 1 (3%)
-Pancreas 14 (47%) 11 (34%)
-Bile duct 7 (23%) 9 (28%)
-Gall bladder 0 (0%) 1 (3%)
-Small bowel 2 (7%) 3 (9%)
-Colon 3 (10%) 4 (13%)
-Rectum 3 (10%) 1 (3%)
-Adrenal gland 0 (0%) 1 (3%)
-Retroperitoneal tumor 0 (0%) 1 (3%)
-Explorative laparotomy 1 (3%) 0 (0%)
Values are means (± SD) or numbers (%)
BMI = Body Mass Index
*: Student t-test for comparison of means; Kruskall-Wallis test for categorical variables
Table 2: Perioperative parameters
Restricted group
(n = 30)
Standard group
(n = 32)
P-value
Insertion level of epidural catheter
-Mid-thoracic (T 6–9) 22 (73%) 25 (78%) 0.77
-Low-thoracic (T 10–12) 3 (10%) 3 (9%) 1.0
-Lumbar 5 (17%) 4 (13%) 0.73
Time of epidural analgesia (days) 3.3 (1.5) 3.7 (1.5) 0.41
Duration of surgical procedure (hrs) 4.3 (2.1) 4.2 (1.7) 0.83
Blood loss during procedure (ml) 450 (435 to 1089) 500 (424 to 1688) 0.65
Urine production during procedure (ml) 315 (249 to 531) 290 (248 to 529) 0.86
IV crystalloids (Ringer's Lactate)
1st hr (ml.kg-1 bodyweight) 20 (6.3) 19 (5.5) 0.45
2nd etc. hrs (ml.kg-1 bodyweight) 8.3 (4.1) 9.0 (3.7) 0.52
IV colloids (HAES-Steril® 6%) (l) 0.9 (0.5) 1.1 (0.9) 0.13
Patients requiring PRC 21% 11% 0.35
PRC = Packed Red Cells. Two patients in the restricted group and one in the standard group required 2 PRC units or more.
Values are expressed as means (± SD) or numbers (%). For blood loss and urine production, medians with 95% Confidence Intervals are given.Page 6 of 11
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This randomized clinical trial shows that a restricted post-
operative intravenous fluid management in rather com-
plex patients undergoing major abdominal surgical
procedures under a combination of epidural and bal-
anced general anesthesia can induce an increased risk of
developing (major) postoperative complications together
with a prolonged postoperative hospital stay, and there-
fore can be harmful for such patients. Based on previous
reports, a reduction of postoperative fluid supply was
expected to be beneficial in terms of postoperative com-
plications and hospital stay. Therefore, we were surprised
by the contrasting findings of this trial regarding these
very endpoints.
The trial was terminated after one year of inclusion,
although the preset number of patients enrolled into the
study was not met, e.g. because the clinical situation of
several included patients deteriorated postoperatively to
such an extent that the surgeon in charge was quite
uncomfortable with the (unknown) amount of fluid
given and decided to unmask the treatment, thereby caus-
ing several protocol violations. No significant difference
between the number of patients unmasked in the SFR
group vs. the RFR group was found. It is reasonable to
infer that patients after unmasking will have received extra
fluid, although the exact amount was not recorded in
detail. However, it is highly unlikely that thereby the RFR
group could have received more fluid in total than the SFR
group. Furthermore, it is known that protocol violations
in a trial can best be handled by performing an intention-
to-treat analysis because any other analysis might intro-
duce bias [23]. So, our findings are in contrast to previous
reported trials that suggest postoperative fluid restriction
to be beneficial and safe [13,14,18]. Furthermore, the
methodological quality of this trial is high as compared to
previous trials. This is based on the allocation conceal-
ment, the blinding of patients, treating surgeons and out-
come assessors, and the data acquisition and checking by
two investigators independently.
Table 3: Intention to treat analysis of the primary and secondary endpoints
Restricted
(n = 30)
Standard
(n = 32)
Absolute Risk Reduction (95% confidence interval)
Postoperative hospital stay (days), mean (SD) 12.3 (12.7) 8.3 (4.5)
Median (IQR) 9.0 (6.8–11.3) 7.0 (6.0–9.8) 0.049*
SECONDARY ENDPOINTS
Postoperative complications 23 13 0.360 (0.133 to 0.588)
- Major complications 12 5 0.244 (0.028 to 0.460)
- Death 1 0
- Cardiac 2 0
- Leakage of anastomosis 6 1 0.135 (-0.011 to 0.282)
- Re-admission 3 4
- Minor complications 11 8 0.117 (-0.112 to 0.345)
- Wound infection 5 1
- Wound dehiscence 1 0
- Infection 0 1
- Respiratory 1 0
- Bleeding 1 3
- Thromboembolism 1 0
- Miscellaneous 2 3
Gastric function
- First flatus (days) 2.8 (1.3) 2.9 (1.5)
Median (IQR) 3 (2–3) 3 (1–4) 0.713*
- First defecation (days) 3.7 (1.3) 3.5 (1.7)
Median (IQR) 4 (3–4) 4 (2–5) 0.725*
- Removal nasogastric tube (days) 2.3 (1.3) 2.4 (2.9)
Median (IQR) 2 (1–3) 2 (1–2) 0.393*
- Removal of epidural catheter (days) 3.3 (1.5) 3.7 (1.5)
Median (IQR) 4 (2–4) 4 (3–4) 0.420*
- Removal of IV catheter (days) 4.9 (2.7) 5.1 (4.5)
Median (IQR) 4 (3–5) 4 (3–5) 0.648*
- Normal diet (days) 4.3 (1.9) 4.2 (3.2)
Median (IQR) 4 (3–5) 4 (3–4) 0.254*
* = p-values according to Mann-Whitney U testPage 7 of 11
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authors are quite variable [10,19]. This also holds for fluid
'restriction', which ranges from maintaining preoperative
body weight to 2 l in the first 24 h [14,18]. The different
effects found may be explained by several reasons. Firstly,
the patients included in this study underwent a wider
range of more major surgical interventions under epidural
analgesia. This was neither the case in the study of Lobo et
al. [17], in which all patients underwent hemicolectomies
or sigmoidectomies, nor in the studies by Brandstrup et al.
[14] and MacKay et al. [18], who included only patients
undergoing colorectal resections, one third of whom per-
formed via laparoscopy. Secondly, in the study of Brand-
strup et al., considerably more patients with ASA 1
classification (almost 50%) were included [14]. This is in
contrast with our study, where most patients were classi-
fied as ASA 2 and 3(about 85%). Lobo et al. did not report
the ASA classification, but their exclusion criteria very
likely prohibited inclusion of patients classified as ASA 3
[17]. Thus, our patients were at a higher perioperative risk
due to the higher prevalence of co-morbidity and there-
fore, they may have benefited from a more conventional
fluid intake. Thirdly, in our study an extensive blinding
procedure was followed of patients, physicians, as well as
nurses, whereas in the studies by Lobo et al. [17], Brand-
strup et al. [14], and MacKay et al. [18], only the outcome
assessor was blinded. This single blinding may have
caused performance bias in favor of the restricted fluid
regime in those studies. On the other hand, a small study
by Holte et al. did not show a clear benefit from fluid
restriction in fast track surgical patients. Rather, they
found a tendency to increased morbidity in the fluid
restricted group [21].
The administration of IV fluid to avoid dehydration and
maintenance of circulating volume with prevention of
inadequate tissue perfusion should be considered along
with maintenance of hypnosis, pain relief and muscle
relaxation, a cornerstone of anesthesia practice [24]. The
effect of anesthetic and postoperative analgesic tech-
niques on outcome varies with the type of operation that
is performed [25]. Although, most adverse morbid out-
comes in high-risk patients undergoing major abdominal
surgery are not reduced by use of a combined epidural and
general anesthesia technique, the improvement in analge-
sia and reduction in respiratory failure and the low risk of
serious adverse events makes it likely that high-risk
patients undergoing major intra-abdominal surgery will
benefit from this combination technique [26,27]. Never-
theless, after the publication of the MASTER study, the use
of this combination of techniques has declined in some
parts of the world [28].
Compensatory intravascular volume expansion, necessary
to compensate for venous dilation and cardiac depression
due to anesthesia and external and third space losses, is
the classic argument used for fluid administration guide-
lines [29]. All our patients received an epidural and during
Table 4: Per protocol analysis of primary and secondary endpoints
Restricted
(n = 18)
Standard
(n = 25)
Absolute Risk Reduction (95% confidence interval)
Primary endpoint
Postoperative hospital stay (days), mean (SD) 7.9 (2.4) 7.3 (3.0)
Median (IQR) 7.0 (6.0–10.0) 7.0 (5.5–8.0) 0.337*
Secondary endpoints
Postoperative complications 4 6 -0.018 (-0.273 to 0.237)
- Major complications 1 3 -0.064 (-0.230 to 0.101)
- Re-admission 1 3
- Minor complications 3 0 0.047 (-0.168 to 0.261)
- Wound infection 3 0
Gastric function
- First flatus (days) 2.5 (1.2) 2.8 (1.5)
Median (IQR) 3 (1.3–3) 3 (1–4) 0.569*
- First defecation (days) 3.5 (1.2) 3.3 (1.6)
Median (IQR) 4 (2.8–4) 4 (2–5) 0.958*
- Removal nasogastric tube (days) 2.1 (1.2) 1.8 (1.2)
Median (IQR) 2 (1–3) 1(1–2) 0.471*
- Removal of epidural catheter (days) 3.5 (1.3) 3.6 (1.3)
Median (IQR) 4 (3–4) 4 (3–4) 0.707*
- Removal of IV catheter (days) 3.9 (1.1) 3.8 (1.3)
Median (IQR) 4 (3–5) 4 (3–5) 0.801*
- Normal diet (days) 3.8 (1.6) 3.6 (1.7)
Median (IQR) 4 (2–5) 3 (3–4) 0.577*
* = p-values according to Mann-Whitney U testPage 8 of 11
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with balanced anesthesia was used in all of them. To com-
pensate for cardiovascular effects, both patient groups
received 500 ml hydroxyethyl starch at the start of the
operation procedure (Appendix). By standardizing the
intra-operative IV fluid regime both patient groups
reached the point of randomization, just after surgery was
finished, in a more or less equal "filling state" also; i.e. no
significant differences were found in the perioperative var-
iables shown at Table 2. Therefore it seems unlikely that
the RFR group could have had much added harm of the
restricted fluid regime in comparison with the standard
fluid regime by having epidural analgesia.
Recently published reviews address the struggle of periop-
erative fluid management decision making in clinical
practice due to the lack of evidence for choosing a "wet"
vs. "dry" regimen for a particular surgical procedure
[1,4,24]. These studies not only suggested to study more
patients undergoing specific surgical procedures, but also
to examine intermediate fluid regimens [1,4,24]. Another
difficulty with properly interpreting the results of the pub-
lished studies is the difference in time schedules regarding
the applied fluid infusion regime. In the study of Lobo
and colleagues the patients in the standard group received
a water load of 40 ml/kg (around 20 ml/kg/h) and in the
restricted group of 34 ml/kg (around 17 ml/kg/h) during
the operation [17]. However, they merely randomized the
post-operative fluid management 3 L (1 L saline and 2 L
dextrose 5%) vs. 2 L (0.5 L saline and 1.5 L dextrose 5%)
[17]. The study of Brandstrup and colleagues not only ran-
domized the complete perioperative fluid infusion regi-
mens, but also mixed colloid and crystalloid regimens,
which makes the study very difficult to interpret [14].
Nisanevich and colleagues randomized the intraoperative
fluid regime (around 15 ml/kg/h vs. 4 ml/kg/h) and
blinded the postoperative caregivers, which resulted in
administering around 2 L fluid/day postoperatively in
both groups of patients, of which 65–70% had underwent
colorectal surgery [15]. In our study, in which around
66% of the patients underwent pancreatic or bile duct sur-
gery, the applied intraoperative fluid management can be
considered as an intermediate fluid regime (around 11
ml/kg/h). Therefore, the differences found can be
explained by the variation in postoperative fluid regime
only.
Many clinicians would prefer to titrate fluid therapy to
some form of clinical response. Historically, e.g. urine
output was considered such a monitoring tool. Lobo et al
however, found no correlation between the allocated fluid
regime and urine output; i.e. none of their patients
became oliguric or showed a concentration increase of
urea in blood above the upper limit of normal and the
restricted group had a decreased PHS [17]. The results of
our study just showed the opposite for PHS. Given this
evidence and the fact that PHS may be influenced by
many other factors besides the impossibility to titrate flu-
ids in this trial, the artificial construct of having postoper-
ative fluid therapy restricted to a fixed rate cannot be the
only cause for the result. Still, tissue perfusion indices as
goals for fluid management stay intuitively very appealing
[4]. Although at present e.g. Stroke Volume Variation and
Esophagus Doppler are subject of research, use of this
information to guide fluid therapy must still gain support
from clinical trial data [4,30]. The mentioned monitors
can e.g. easily be used in an ICU setting, but are less or not
suitable for monitoring purposes in patient admitted at a
regular ward and therefore will have less efficiency for
influencing longer term outcomes as PHS.
Because we performed an outcome study instead of a
pathophysiological study, in which measurements of dif-
ferent fluid compartments usually are subject of study, it
is difficult to provide a pathophysiological explanation of
the increased complication rate in the RFR group. Inflam-
mation, effects on microcirculation, induced cellular leak-
age, differences in fluid load are amongst items that may
play a role [31]. Moreover, recently it became clear that
the theoretical models used to describe mechanisms of
water movements, e.g. in the digestive tract are incom-
plete [32].
Our study showed an unexpected high anastomotic leak-
age rate (6 out of 30 patients) in the restricted regime
group, for which we do not have an explanation, but
which is in contrast with the study of Brandstrup et al.
[14]. Apart from the existing belief in the conventional
fluid administration and the cumbersome execution of
the trial, the observed harmful effects led to the decision
to prematurely stop the trial. However, the clearly signifi-
cant findings cannot only be explained by a possibly false-
positive result, as might be the case in trials stopped for
early benefit [33]. Our per-protocol analysis did not show
any significant differences between groups, which is not
surprising as in this analysis the patients with complica-
tions were not included.
Lessons learnt from this trial
We designed a trial in which all stakeholders were blinded
to the treatment given in order to tackle many possible
sources of bias and, at the same time, to stay as close as
possible to common clinical practice. In trials about fluid
regimens this blinding procedure appears feasible. How-
ever, in this trial the many patients with hypovolaemia
and low blood pressure led to a substantial number of
protocol violations. A weight-based regime together with
stricter predefined daily laboratory testing may enable
better protocol adherence. On the other hand, additional
measures to assess efficacy in a trial, e.g. directly postoper-
ative body weight measurements, lab testing, or even
more attention to the patient's condition, are beyondPage 9 of 11
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tions for real life that can be drawn from such a study. Fur-
thermore, the inclusion speed in this study was lower than
expected, because many eligible patients could not be
included as they were already participating in other con-
current clinical trials. Future trials should try and include
a consecutive set of eligible patients or be conducted in a
multicenter fashion in order to obtain sufficient and gen-
eralisable data. Finally, our conclusion contrasts with the
results of other studies. This might be the result of the
rigid design including the blinding procedure and the fact
that the large majority of patients underwent major sur-
gery. Hence, results from trials in this multifaceted area of
research should be interpreted carefully and with an eye
on the case-mix of patients included.
In conclusion: this trial suggests that a restricted postoper-
ative IV fluid regime of 1.5 L/24 h appears harmful to
patients undergoing major abdominal surgery. The find-
ings should be reconfirmed in a larger trial of good design
and conduct. In such a trial one should anticipate the
threat of protocol violation as a result of (elaborate)
blinding.
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Appendix
Standardized intra-operative IV fluid regime
Basic IV infusion regime by giving crystalloids during the
surgical procedure:
-1st hour of the procedure: 20 ml per kg body weight of
Ringer's Lactate
-2nd and further hours: 6 ml per kg body weight of
Ringer's Lactate
Colloid IV infusion and blood transfusion regime to com-
pensate for cardiovascular effects of epidural analgesia
and blood loss during the surgical procedure:
-500 ml hydroxyethyl starch (HAES-Steril® 6% [Fresen-
ius-Kabi AG, Bad Homburg v.d. H., Germany]) was
given at the start of the procedure
-When blood loss ≥ 500 ml, a 2nd 500 ml hydroxyethyl
starch (HAES-Steril® 6%) was given
-When blood loss ≥ 1,000 ml, a 3rd 500 ml hydroxye-
thyl starch (HAES-Steril® 6%) was given
-When blood loss ≥ 1,500 ml:
• Packed Red Cells (PRC) were given guided by
Haemoglobin (Hb) level
Patient < 70 yrs: trigger Hb-level = 5·0 mmol.l-1 (=
8·1 g.dl-1)
Patient ≥ 70 year: trigger Hb-level = 5·5 mmol.l-1
(= 8·9 g.dl-1)
• When > 2 units PRC were necessary: 2 units PRC
were alternated with 1 unit plasma in order to
maintain adequate blood coagulation
• If the trigger Hb-level was not met it was allowed
to give a 4th hydroxyethyl starch (HAES-steril® 6%)
but only in case the first one was being adminis-
tered ≥ 6 h ago. Otherwise IV infusion of Ringer's
lactate was then given
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